Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry B Ernest

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
AAPS Pharmscitech|June 20, 2018
Co-Processed Excipients for Dispersible Tablets-Part 1: ManufacturabilityBen J Bowles, Karolina Dziemidowicz, Felipe L Lopez, et al.
Scientific Reports|June 17, 2018
Acceptability of placebo multiparticulate formulations in children and adultsFelipe L Lopez, Punam Mistry, Hannah K Batchelor, et al.
Drugs|October 3, 2014
Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populationsFang Liu, Sejal Ranmal, Hannah K Batchelor, et al.
International Journal of Pharmaceutics|May 12, 2015
Formulation factors affecting acceptability of oral medicines in childrenFang Liu, Sejal Ranmal, Hannah K Batchelor, et al.
The Lancet. Child & Adolescent Health|December 6, 2021
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trialIván D Vélez, Tran T Hien, Justin A Green, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
AAPS Pharmscitech|June 20, 2018
Co-Processed Excipients for Dispersible Tablets-Part 1: ManufacturabilityBen J Bowles, Karolina Dziemidowicz, Felipe L Lopez, et al.
Scientific Reports|June 17, 2018
Acceptability of placebo multiparticulate formulations in children and adultsFelipe L Lopez, Punam Mistry, Hannah K Batchelor, et al.
Drugs|October 3, 2014
Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populationsFang Liu, Sejal Ranmal, Hannah K Batchelor, et al.
International Journal of Pharmaceutics|May 12, 2015
Formulation factors affecting acceptability of oral medicines in childrenFang Liu, Sejal Ranmal, Hannah K Batchelor, et al.
The Lancet. Child & Adolescent Health|December 6, 2021
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trialIván D Vélez, Tran T Hien, Justin A Green, et al.
Pageof 2